ScholarWorks@Korea University: Choi, Kyung Mook

Detailed Information

Choi, Kyung Mook (최경묵)

College of Medicine (Department of Medical Science)

Research Area

Tel 02-2626-3043
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Obesity:13||Diabetes mellitus, type 2:10||Diabetes mellitus:10||Inflammation:9||Metabolic syndrome:9||Atherosclerosis:8||metabolic syndrome:7||Sarcopenia:7||Korea:7||Practice guideline:7||Type 2 diabetes:6||sarcopenia:6||Hypoglycemic agents:6||Adipokines:5||obesity:5||insulin resistance:5||type 2 diabetes:5||Insulin resistance:5||ER stress:5||variability:5||Insulin:4||Nonalcoholic fatty liver disease:4||atherosclerosis:4||s disease:4||hypertension:4||AMPactivated protein kinase:4||Muscle:4||type 2:4||Hepatokine:4||Nonalcoholic fatty liver disease:4||AMPK:3||Arterial stiffness:3||mortality:3||positron emission tomography:3||Alzheimer&apos:3||adipokine:3||Cholesterol:3||Apoptosis:3||Clinical practice guideline:3||Adiponectin:3||Body composition:3||nonalcoholic fatty liver disease:3||Selenoprotein P:3||Glucose:3||Cardiovascular disease:3||aging:3||Menopause:3||inflammation:3||Pulse wave velocity:3||dementia:3||Heart failure:3||Dementia:3||FetuinA:3||vascular dementia:2||Body size phenotype:2||Atorvastatin:2||cardiovascular disease:2||Nonalcoholic fatty liver:2||Skeletal:2||osteoporosis:2||Vascular stiffness:2||stroke:2||Endothelial cells:2||body composition:2||adiponectin:2||Muscle mass:2||cJun Nterminal kinase:2||Dipeptidyl peptidaseIV inhibitors:2||Diabetes:2||visceral obesity:2||Positron emission tomography:2||Sarcopenic obesity:2||gammaglutamyl transferase:2||Risk factors:2||Salsalate:2||Osteoporosis:2||Parkinson&apos:2||Metformin:2||Aging:2||비만:2||Abdominal fat:2||cardiovascular mortality:2||Oral hypoglycemic agents:2||Fibroblast growth factor 21:2||Leukocyte cellderived chemotaxin 2:2||Dyslipidemias:2||LDL:2||Mortality:2||Type 2 diabetes mellitus:2||Body mass index:2||Efficacy:2||diabetes mellitus:2||visfatin:2||Allcause mortality:1||epidemiology:1||HydroxymethylglutarylCoA reductase inhibitors:1||public health:1||Hypertriglyceridemia:1||cardiometabolic disease:1||crosssectional study:1||type 2 diabetes mellitus:1||triple therapy:1||lipoprotein:1||Chronic kidney disease:1||Renal function:1||Glucagonlike peptide1 receptor agonist:1||Monotherapy:1||leukocyte telomere length:1||Fatigue:1||health disparity:1||Autophagy:1||Endoplasmic reticulum stress:1||abdominal fat computed tomography:1||Korean:1||HIF1:1||Stable angina pectoris:1||Type2 diabetes mellitus:1||Body fat composition:1||vitamin D:1||Lisinopril:1||receiver operating characteristic curve analysis:1||Type 1 diabetes:1||chronic disease:1||대사증후군:1||SOLUBLE RECEPTOR:1||ASSOCIATION:1||fatty liver disease:1||liver steatosis:1||Sestrin2 protein:1||Cell adhesion molecules:1||Special Editorial:1||Frailty:1||Gestational diabetes mellitus:1||radioactive iodine treatment (RAI treatment):1||Diabetes mellitus Glucose variability:1||cardiac risk factors and prevention:1||Life style:1||muscle strength:1||preventive medicine:1||estimated glomerular filtration rate:1||urine dipstick test:1||gestational diabetes mellitus:1||democratic people&apos:1||Liver:1||glycemic variability:1||Sulfonylurea:1||Protectin DX:1||Skeletal muscle mass index:1||Metrnl:1||Cardiovascular benefit:1||Meal frequency:1||Korean National Health and Nutrition Examination Survey:1||Hypothyroidism:1||Gestational diabetes:1||Intraabdominal fat:1||polycystic ovary syndrome:1||SARCOPENIA:1||Subclinical Atherosclerosis:1||Aspirin resistance:1||glycoproteome:1||Acute coronary syndrome:1||Adipocyte fatty acid binding protein:1||Salicylate:1||Vascular adhesion molecules:1||Chemerin:1||Type 2 diabetic rats:1||depression:1||hyperlipidemia:1||F18fluorodeoxyglucose positron emission tomography:1||prevalence:1||metabolic syndrome X:1||Glycaemic variability:1||PLASMALEVELS:1||elderly:1||Fasting plasma glucose variability:1||Variability:1||mouse:1||Adipose tissue:1||brown:1||Gproteincoupled 40:1||Gammaglutamyltransferase:1||Heart rate:1||Muscle strength:1||Cohort:1||cardiovascular disease (CVD):1||Ginsenoside Mc1:1||pathophysiology:1||Antioxidant:1||lean body mass:1||chronic kidney disease:1||bone density:1||s republic of korea:1||Diabetic nephropathies:1||Skeletal muscle:1||Pathophysiology:1||Bone muscle interaction:1||DPP4 inhibitor:1||fetuinA:1||sRAGE:1||interleukin6:1||parathyroid carcinoma:1||Vascular inflammation:1||CARDIOMETABOLIC DISEASE:1||Body size phenotypes:1||Anthropometric index:1||Hepatokines:1||Resolvin D1:1||NONALCOHOLIC FATTY LIVER DISEASE:1||ER STRESS:1||Metabolically abnormal but normal weight:1||nonobese:1||type 2 diabetic nephropathy:1||C1q/tumor necrosis factorrelated protein3:1||Progranulin:1||lipocalin2:1||NAFLD:1||Phosphodiesterase inhibitor:1||obstructive sleep apnea:1||Fat mass:1||Hyperprolactinemia:1||skeletal muscle:1||sleep duration:1||Lifestyle modification:1||Diabetes complications:1||ENDOGENOUS SECRETORY RAGE:1||CREACTIVE PROTEIN:1||Muscle development:1||Body weight:1||Disability incidence:1||Republic of Korea:1||Stroke:1||AMPactivated protein kinases:1||body weight:1||s dementia:1||geriatric medicine:1||big data:1||omega3:1||Low skeletal muscle mass:1||sleep:1||Cardiocerebrovascular disease:1||Endstage renal disease:1||sitagliptin:1||skeletal:1||irisin:1||FTO polymorphism:1||Thiazolidinediones:1||high carbohydrate:1||Heart rate variability:1||Lcarnitine:1||endoplasmic reticulum stress:1||AMPKactivated protein kinase:1||peroxisome proliferatoractivated receptors:1||ANGPTL8:1||SARCOPENIC OBESITY:1||Sleep duration:1||HEPATIC STEATOSIS:1||glycation:1||short sleep duration:1||렙틴:1||Epidemiology:1||Type 2:1||Liver cirrhosis:1||Aldosterone receptor blocker:1||skeletal muscle mass:1||Computed tomography:1||Subcutaneous fat:1||highsensitivity Creactive protein:1||visceral fat:1||인슐린 저항성:1||Glycated hemoglobin A:1||VASCULAR INFLAMMATION:1||fracture:1||hepatic steatosis index:1||Hepatic steatosis:1||retrospective cohort study:1||Alzheimer disease:1||Sclerostin:1||gammaglutamyltransferase:1||myocardial infarction:1||teneligliptin:1||Albuminuria:1||low muscle mass:1||myokines:1||Sesn2:1||Proinflammatory reactions:1||Glycemic variability:1||Cardiac autonomic dysfunction:1||Coronary artery calcification:1||angiotensin II type 1 receptor blockers:1||ANGPTL3:1||HDL:1||Cardiomyocytes:1||LIPOAPOPTOSIS:1||CHOP:1||NonHDL cholesterol:1||fructosamine:1||Framingham risk score:1||BuddChiari syndrome:1||abdominal obesity:1||esRAGE:1||Telmisartan:1||Cohort studies:1||Midlife:1||GLYCATION ENDPRODUCTS:1||Graves disease:1||occupational health:1||thyroid cancer:1||Muscular atrophy:1||Thyroid neoplasms:1||The Korean National Health Insurance Corporation:1||cardiometabolic disorders:1||adipocyte:1||Cardiomyocyte:1||sarcopenic obesity:1||total cholesterol:1||Clinical practice guidelines:1||Cardiovascular diseases:1||glycemic load:1||Fatigue scale:1||Triglycerides:1||Sleep apnea, obstructive:1||cJun Nterminal kinases:1||adipocyte fatty acidbinding protein:1||Proliferatoractivated receptorgamma:1||NF kappa B:1||Lowdensity lipoprotein cholesterol:1||Vitamin D:1||Obesity metabolism:1||Cilostazol:1||Highsensitivity Creactive protein:1||Adiposity:1||Sodium intake:1||National survey:1||RAGE:1||Diabetic nephropathy:1||resistin:1||Differentiated thyroid cancer:1||nonalcoholic fatty liver disease:1||Elderly:1||Visittovisit:1||ATHEROSCLEROSIS:1||blood pressure:1||Koreans:1||metabolic diseases:1||thyroidectomy:1||Comorbidity:1||Triglyceride:1||Triglycerideglucose index:1||Metabolic health:1||older people:1||Wnt pathway:1||Dipeptidyl peptidase4 inhibitors:1||Oxidative stress:1||diet:1||Waist circumference:1||Combination therapy:1||Hypoglycemia:1||Endothelium:1||glucose tolerance:1||glycemic index:1||intraoperative parathyroid hormone assay:1||Wessely and Powell score:1||socioeconomic status:1||Angiopoietinlike protein 4:1||Pooled cohort risk scores:1||unfolded protein response:1||glucagonlike peptide1:1||fat distribution:1||VISCERAL OBESITY:1||Metabolically healthy but obese:1||Atherogenic dyslipidemia:1||hypertriglyceridaemia:1||biomarker:1||Omentin1:1||Leptin:1||아디포카인:1||아디포넥틴:1||Health Insurance Review &:1||Assessment Service:1||Eplerenone:1||Visceral fat:1||waist circumference:1||impaired glucose tolerance:1||Fulminant:1||diabetes:1||복부 비만:1||Valsartan:1||Community networks:1||GLYCEMIC CONTROL:1||highnormal blood pressure:1||Radioiodine ablation:1||Hyperthyroidism:1||Blood pressure:1||Health behavior:1||Risk assessment:1||morbidity:1||vascular:1||Fatty acids:1||Waisttohip ratio:1||glucose:1||REPUBLIC OF KOREA:1||Beraprost:1||abdominal:1||Sestrin2:1||melatonin:1||Cardiometabolic risk factors:1||metabolic disease:1||Dipeptidylpeptidase IV inhibitors:1||fiber:1||Muscles:1||C1q/TNFRelated Protein 9:1||Dipeptidyl peptidase4 inhibitor:1||Fatty liver:1||betaAminoisobutyric acid:1||weight loss:1||Coronary artery disease:1||MHO:1||sleep disordered breathing:1||Angiotensinconverting enzyme insertion/deletion polymorphism:1||Genderdependent association:1||Steatosis:1||vascular inflammation:1||Antipsychotic agents:1||internet:1||Korean National Health and Nutrition Survey:1||Low income:1||Fasting plasma glucose:1||ENDOTHELIAL FUNCTION:1||prehypertension:1||Antithyroid agents:1||thyroid function:1||Adrenergic beta3 receptor agonists:1||Human umbilical vein endothelial cells:1||Receptors:1||Sex difference:1||Disease management:1||Prevalence:1||

STATISTICS: Total View :6,942,232; Today View :8,301

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE